Develops drugs for rare liver and bile diseases.
Jun 2026Revenue $618M/yrExpenses $1.45B/yr
No trendCash runway ≈ 1.9 years from Jun 2026
Figures by year
When will Mirum Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $618M and expenses $1.45B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $521M | $543M | −$22.1M |
| Dec 2024 | $337M | $424M | −$87.6M |
| Dec 2023 | $186M | $296M | −$109M |
| Dec 2022 | $77.1M | $208M | −$131M |
| Dec 2021 | $19.1M | $193M | −$173M |
| Dec 2020 | $0.00 | $104M | −$104M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.